ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,417Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 1004

$1.67M Total Retail Price of All Prescriptions

Rank: 3 out of 1004

737 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Massachusetts
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

17% of this provider’s 737 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 737 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,916 1,646 71 1 11
LEVOTHYROXINE SODIUM 1,255 1,112 129 2 4
FUROSEMIDE 1,104 1,076 152 3 9
LISINOPRIL 929 834 148 4 1
METOPROLOL TARTRATE 839 758 125 5 12
AMLODIPINE BESYLATE 780 717 107 6 5
SIMVASTATIN 776 729 119 7 2
QUETIAPINE FUMARATE 748 713 84 A 8 49
TRAZODONE HCL 742 654 130 9 18
NAMENDA 683 678* 54 10 31
DONEPEZIL HCL 649 626 90 11 27
SERTRALINE HCL 626 581 86 12 22
CITALOPRAM HBR 565 500 82 13 15
OMEPRAZOLE 560 465 120 14 3
MIRTAZAPINE 511 486 82 15 35
GABAPENTIN 469 377 71 16 14
ABILIFY 419 331 21 A 17 79
DIVALPROEX SODIUM 358 286 50 18 60
LACTULOSE 328 311 76 19 110
TAMSULOSIN HCL 318 313* 48 20 29
LORAZEPAM 294 264 100 B 21 17
RISPERIDONE 282 245 41 A 22 57
LANTUS 272 261 63 23 50
METOPROLOL SUCCINATE 267 262* 43 24 13
METFORMIN HCL 254 240 38 25 8
ATORVASTATIN CALCIUM 251 246* 43 26 7
POTASSIUM CHLORIDE 231 212 44 27 39
VESICARE 226 203 14 28 112
RANITIDINE HCL 225 208 50 29 28
POLYETHYLENE GLYCOL 3350 224 180 70 30 58
FLUOXETINE HCL 221 178 33 31 44
HYDROCHLOROTHIAZIDE 219 198 35 32 6
OLANZAPINE 212 194 26 A 33 72
IPRATROPIUM-ALBUTEROL 207 184 71 34 107
CARVEDILOL 204 199* 31 35 59
CYMBALTA 196 164 22 36 54
CLOPIDOGREL 195 165 29 37 33
ATENOLOL 190 185* 33 38 10
GLIPIZIDE 185 173 27 39 52
LIDODERM 181 176* 35 40 86
ESCITALOPRAM OXALATE 179 174* 27 41 78
DIOVAN 171 166* 17 42 51
FAMOTIDINE* 168 129 35 43 105
TRAMADOL HCL 165 149 41 44 23
ADVAIR DISKUS 160 155* 32 45 46
CELEBREX 159 148 15 46 87
PREDNISONE 159 130 40 46 47
ALLOPURINOL 155 150* 21 48 34
CIPROFLOXACIN HCL 155 140 80 48 99
PAROXETINE HCL 149 127 20 50 55
LEVEMIR FLEXPEN 145 132 24 51 163
LOVASTATIN 145 128 23 51 32
CEPHALEXIN 138 133* 54 53 145
BACLOFEN 131 90 19 54 100
ISOSORBIDE MONONITRATE ER 130 125* 19 55 62
SPIRONOLACTONE 129 118 24 56 89
OXYCODONE HCL 127 104 58 S2 57 25
NYSTATIN 124 119* 63 58 117
ALENDRONATE SODIUM 123 110 23 59 24
CARBIDOPA-LEVODOPA 123 111 19 59 101
COLCRYS 119 106 14 61 157
LEVOFLOXACIN 114 109* 72 62 102
FLUTICASONE PROPIONATE 114 109* 35 62 26
NEXIUM 113 61 21 64 93
SPIRIVA 109 104* 26 65 45
OXYBUTYNIN CHLORIDE ER 109 104* 18 65 95
PANTOPRAZOLE SODIUM 109 104* 20 65 37
NIFEDIPINE ER 109 <11 <11 65 80
NYAMYC 107 102* 57 69 219
HUMALOG 106 101* 34 70 143
PRAVASTATIN SODIUM 105 85 23 71 16
LEVETIRACETAM 103 81 13 72 104
DIGOX 99 85 20 73 81
HYDROCODONE-ACETAMINOPHEN 99 94* 38 S3 73 20
AZITHROMYCIN 90 85* 54 75 94
CLONIDINE HCL 90 85* 15 75 124
NOVOLOG 90 85* 21 75 120
DETROL LA 89 <11 <11 78 125
TRIAMCINOLONE ACETONIDE 87 82* 26 79 134
AMANTADINE 86 <11 <11 80 259
LABETALOL HCL 86 86 12 80 135
NOVOLOG FLEXPEN 84 69 21 82 226
PHENYTOIN SODIUM EXTENDED 84 <11 <11 82 152
FINASTERIDE 83 83 14 84 66
AGGRENOX 83 <11 <11 84 183
HALOPERIDOL 83 <11 <11 A 84 138
DILTIAZEM 24HR CD 81 67 13 87 130
NITROFURANTOIN MONO-MACRO 80 75* 55 88 196
GALANTAMINE HBR 80 <11 <11 88 159
TERAZOSIN HCL 78 73* 12 90 76
NOVOFINE AUTOCOVER 70 58 25 91 275
CLONAZEPAM 70 65* 20 B 91 40
TOPIRAMATE 70 <11 <11 91 129
HYDRALAZINE HCL 65 51 13 94 123
MONTELUKAST SODIUM 65 65 11 94 69
METHENAMINE HIPPURATE 64 <11 <11 96 284
VANCOMYCIN HCL* 64 64 12 96 242
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 58* 43 98 153
KETOCONAZOLE 63 58* 29 98 180
MORPHINE SULFATE ER 62 37 22 S2 100 68
VENLAFAXINE HCL 62 <11 <11 100 193
ENALAPRIL MALEATE 61 <11 <11 102 65
ENOXAPARIN SODIUM 61 19 11 102 182
DILTIAZEM ER 60 <11 <11 104 242
CARBAMAZEPINE 60 <11 <11 104 161
BUPROPION HCL SR 59 48 11 106 118
LATANOPROST 58 58 16 107 146
BENZTROPINE MESYLATE 58 <11 <11 R 107 140
JANUVIA 56 <11 <11 109 74
PROAIR HFA 55 36 25 110 19
LIDOCAINE 55 40 18 110 234
AVODART 54 <11 <11 112 205
FENTANYL 53 33 17 S2 113 103
LOSARTAN POTASSIUM 52 47* 11 114 21
SYMBICORT 51 <11 <11 115 127
BRIMONIDINE TARTRATE 50 <11 <11 116 191
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.